|
|
|
|
|
Calcitonin (salmon) |
|
H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln- |
|
47931-85-1(net) |
|
For the treatment of osteoporosis, paget's disease, hypercalcemia, reflex sympathetic dystrophy (algodistrophy or Sudeck's disease). |
|
Calcitonin (salmon) positively influences bone mass density due to its inhibiting effect on osteoclast activity. |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|